Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers BGNE BMY MRK
Marina Medical Instruments Partners with FAGA to Address Gaps in Surgical Devices
Via Prodigy
Exposures Product Safety
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
Via Benzinga
Exposures Product Safety
Tickers BMY NVO TSVT
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
Via Benzinga
Exposures Product Safety
Tickers EBS
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
Via Benzinga
Exposures Product Safety
Tickers LLY MRK
Creative Biolabs: Lock and Load with Next-Gen mRNA Tech
Via Get News
Topics Death
Exposures COVID-19 Death Product Safety
Florida Cannabis Ballot: NFL's Ricky Williams Backs Legalization, New Ad 'Hypocrisy Of Alcohol Vs. Marijuana'
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
Via FinancialNewsMedia
Exposures Product Safety
Tickers AMRX LLY NTRB NTRBW
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU announced
Via PR Leap
Exposures Product Safety
Graphic Cabin™ by Hatfield Creative: Your Local Partner for Custom Beverage Labels, Wall Decals, and Trade Show Displays
Via Syndication Cloud
Exposures Product Safety
Cybersecurity for Medical Devices: 4 Ways to Remain Compliant
Via Syndication Cloud
Exposures Product Safety
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Tickers GILD
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
Via Benzinga
Exposures Product Safety
Tickers BHVN
New Study Warns of High Dose "ADHD" Drugs Inducing Psychosis
Via PRLog
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TNXP
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Via Benzinga
Exposures Product Safety
Tickers SNY
BOQU Instrument Elevates Professional Standards in Water Quality Sensors and Analyzers
Via AB Newswire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Product Safety Supply Chain
Approved for Domestic Market, OT-1001 Ushers in a New Era for Pediatric Allergic Conjunctivitis Treatment
Via AB Newswire
Exposures Product Safety
Burning Daily Announces Enhanced Brand Selection Standards to Ensure Premium Products for Customers.
Via GetFeatured
Topics Supply Chain
Exposures Product Safety Supply Chain
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ICUI
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Via Benzinga
Exposures Product Safety
Tickers ABBV BMY
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
Via Benzinga
Exposures Product Safety
Tickers JNJ
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Via Benzinga
Exposures Product Safety
Tickers JNJ ZVRA
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
Via Benzinga
Exposures Product Safety
Tickers ELAN ZTS
GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GM
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ICUI
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TNXP
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
Via Benzinga
Exposures Product Safety
Tickers VNDA
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
Via Benzinga
Topics Government
Exposures Political Product Safety
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.